FREMONT, California, July 14, 2020
FREMONT, California, July 14, 2020 /PRNewswire/ -- The Global Nucleic Acid Isolation and Purification Market is projected to reach $3.84 billion by 2029, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.98% during the period between 2020 and 2029.
The comprehensive study of global nucleic acid isolation and purification BIS Research extensively covers the following:
Market numbers on micro-segments that are influencing the market
The detailed study is a compilation of 43 Market Data Tables and 296 Figures spread through 389 Pages and in-depth TOC on "Global Nucleic Acid Isolation and Purification Market - Analysis and Forecast, 2020-2029"
Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 1400+ products.
BIS Research study indicates that the increasing number of genetic tests taken, the growing demand for reliable next-generation sequencing (NGS) results, the rising prevalence of infectious diseases, and the improving funding scenario in the field of microbiology, among others, are fueling the growth of the market.
The study highlights the various emerging opportunities, such as growth in emerging nations, capitalization on the high prevalence of genetic disorders, and the evolution of biobanking in healthcare, that can be leveraged by players operating in the market.
The market intelligence by BIS Research additionally throws a spotlight on the key industry trends that have a humungous influence in shaping the industry going forward. Some of these trends include the emergence of advanced stabilization products, regulated vs. multimodal analysis, novel targets for isolation and purification, exploration of new applications, and several other key trends.
View the Report from BIS Research at Global Nucleic Acid Isolation and Purification Market
To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include end-user and pricing analysis, types of products offered, technologies used, sources used, applications, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.
The end-user and pricing analysis of the global market includes data analysis on the satisfaction level of different instruments (by brand), pricing analysis of preferred instruments, accessories & components, and consumables. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and instruments. The consumables are further categorized into kits and reagents.
To emphasize the dominance of the consumable segment over the instruments segment under the product category of nucleic acid isolation and purification market in 2020 and 2029, Nitish Kumar Singh, Lead Analyst – BIS Research, states, "The reason for market growth and the dominance consumable segment can be attributed to the prevalent product type and its widespread use in almost all applications related to the nucleic acid isolation and purification market. It is anticipated that the consistent growth in the utilization of media and kits and reagents will be another reason for the segment to witness a significant growth in the coming years."
Request for a Sample: https://bisresearch.com/requestsample?id=849&type=download
Key insights are drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include Agilent Technologies, Inc., Analytik Jena AG, Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, General Electric Company (G.E.), Illumina, Inc., Merck KGaA, Meridian Bioscience, Inc., Macherey-Nagel GmbH & Co K.G., New England Biolabs, Inc, Norgen Biotek Corp., Omega Bio-Tek, Orasure Technologies, Inc., PerkinElmer, Inc., Promega Corporation, and QIAGEN N.V.
The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.
Who should buy this report?
How market intelligence on nucleic acid isolation and purification can add value to an organization's decision making process?
Insightful Questions Covered to Enable Companies take Strategic Decisions
BIS Research Related Market Studies:
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.
Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as, custom studies, and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.
BIS Healthcare scans, analyzes, and tracks markets to provide superior intelligence and consultations to its clients. Over the years, it has created a knowledge pool through whitepapers, analyst notes, case studies, and customized solutions.
In the past five years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.
BIS Healthcare caters to different facets of the healthcare industry, including Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum.
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch